Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study on the Safety of Leucine-Restricted Diet in Patients With Gastric Cancer

NCT07488312 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.

NCT NCT07488312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07488312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study on the Safety of Leucine-Restricted Diet in Patients With Gastric Cancer
Lead sponsor
Qilu Hospital of Shandong University
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
October 1, 2025
Completion date
December 1, 2026
Enrollment
37 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer